Dianthus Therapeutics (DNTH) Receivables: 2022-2025
Historic Receivables for Dianthus Therapeutics (DNTH) over the last 2 years, with Sep 2025 value amounting to $5.0 million.
- Dianthus Therapeutics' Receivables rose 85.87% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 54.25%. This contributed to the annual value of $494,000 for FY2023, which is 91.18% down from last year.
- As of Q3 2025, Dianthus Therapeutics' Receivables stood at $5.0 million, which was up 12,720.51% from $39,000 recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Receivables ranged from a high of $5.6 million in Q4 2022 and a low of $39,000 during Q2 2025.
- Over the past 3 years, Dianthus Therapeutics' median Receivables value was $917,500 (recorded in 2024), while the average stood at $1.6 million.
- Its Receivables has fluctuated over the past 5 years, first soared by 258.19% in 2024, then plummeted by 97.62% in 2025.
- Dianthus Therapeutics' Receivables (Quarterly) stood at $5.6 million in 2022, then crashed by 91.18% to $494,000 in 2023, then surged by 258.19% to $2.7 million in 2024, then skyrocketed by 85.87% to $5.0 million in 2025.
- Its Receivables was $5.0 million in Q3 2025, compared to $39,000 in Q2 2025 and $1.0 million in Q1 2025.